Does this optic neuritis patient have neuromyelitis optica? An approach to optic neuritis in the context of neuromyelitis optica

被引:1
作者
Burton, Jodie M. [1 ,2 ,3 ,4 ]
Costello, Fiona [1 ,2 ,3 ,5 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Calgary, AB, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[5] Univ Calgary, Dept Surg Ophthalmol, Calgary, AB, Canada
关键词
aquaporin-4; demyelinating disease; Devic's disease; immunosuppression; myelopathy; neuromyelitis optica; neuromyelitis optica spectrum disorder; NMO-IgG; optic neuritis; rituximab;
D O I
10.1586/17469899.2014.922874
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Optic neuritis is a common presentation of demyelinating disease, most often associated with multiple sclerosis, and typically associated with a relatively good recovery and prognosis. However, when optic neuritis is the heralding event of neuromyelitis optica (NMO), it is much more likely to be the start of a devastating and disabling chronic disease with a reduced lifespan. Early recognition of NMO is the best chance a patient has of avoiding life-altering disability, as relapse prevention is essentially disability prevention because this disease, unlike MS, does not really have a progressive component. The following review was written to assist the clinician, particularly the ophthalmologist, in assessing optic neuritis in evaluating and recognizing the potential NMO patient.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 78 条
  • [1] A population-based study of neuromyelitis optica in Caucasians
    Asgari, N.
    Lillevang, S. T.
    Skejoe, H. P. B.
    Falah, M.
    Stenager, E.
    Kyvik, K. O.
    [J]. NEUROLOGY, 2011, 76 (18) : 1589 - 1595
  • [2] Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
    Ayzenberg, Ilya
    Kleiter, Ingo
    Schroeder, Alexandra
    Hellwig, Kerstin
    Chan, Andrew
    Yamamura, Takashi
    Gold, Ralf
    [J]. JAMA NEUROLOGY, 2013, 70 (03) : 394 - 397
  • [3] Optic neuritis
    Balcer, LJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) : 1273 - 1280
  • [4] Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
    Banwell, B.
    Tenembaum, S.
    Lennon, V. A.
    Ursell, E.
    Kennedy, J.
    Bar-Or, A.
    Weinshenker, B. G.
    Lucchinetti, C. F.
    Pittock, S. J.
    [J]. NEUROLOGY, 2008, 70 (05) : 344 - 352
  • [5] Barnett Y, AJNR AM J NEURORADIO
  • [6] A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS
    BECK, RW
    CLEARY, PA
    ANDERSON, MM
    KELTNER, JL
    SHULTS, WT
    KAUFMAN, DI
    BUCKLEY, EG
    CORBETT, JJ
    KUPERSMITH, MJ
    MILLER, NR
    SAVINO, PJ
    GUY, JR
    TROBE, JD
    MCCRARY, JA
    SMITH, CH
    CHROUSOS, GA
    THOMPSON, HS
    KATZ, BJ
    BRODSKY, MC
    GOODWIN, JA
    ATWELL, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) : 581 - 588
  • [7] Impact of rituximab on relapse rate and disability in neuromyelitis optica
    Bedi, Gurdesh S.
    Brown, Andrew D.
    Delgado, Sylvia R.
    Usmani, Nida
    Lam, Byron L.
    Sheremata, William A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (10) : 1225 - 1230
  • [8] Devic's neuromyelitis optica: clinical features and prognostic factors
    Bergamaschi, R
    Ghezzi, A
    [J]. NEUROLOGICAL SCIENCES, 2004, 25 (Suppl 4) : S364 - S367
  • [9] Plasma Exchange in Severe Attacks of Neuromyelitis Optica
    Bonnan, Mickael
    Cabre, Philippe
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
  • [10] Bilateral and recurrent optic neuritis in multiple sclerosis
    Burman, J.
    Raininko, R.
    Fagius, J.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2011, 123 (03): : 207 - 210